Turn $1000 into $750K with These Coins: Catzilla Coin Tops the List with Over 10,000% Potential!
AbbVie’s third successful Parkinson’s trial sets the stage for an eventful 2025
AbbVie’s third successful Parkinson’s trial sets the stage for an eventful 2025
AbbVie Inc. announced positive data from a third late-stage trial of a treatment for Parkinson’s disease on Monday and said it’s on track to seek approval for the drug from the Food and Drug Administration in 2025.
